Nuveen
MCRB icon

Nuveen’s Seres Therapeutics MCRB Stock Holding History

Nuveen’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.17K Buy
+1,773
New +$8.94K ﹤0.01% 4636
2023
Q4 		– Sell
-13,974
Closed -$665K – 3337
2023
Q3 		$665K Sell
13,974
-73
-0.5% -$5.57K ﹤0.01% 2741
2023
Q2 		$1.35M Sell
14,047
-4,438
-24% -$483K ﹤0.01% 2522
2023
Q1 		$2.1M Buy
18,485
+3,266
+21% +$353K ﹤0.01% 2311
2022
Q4 		$1.7M Sell
15,219
-8,017
-35% -$1.07M ﹤0.01% 2462
2022
Q3 		$2.98M Buy
23,236
+12,993
+127% +$1.33M ﹤0.01% 2179
2022
Q2 		$702K Sell
10,243
-2,452
-19% -$211K ﹤0.01% 2930
2022
Q1 		$1.85M Buy
12,695
+653
+5% +$100K ﹤0.01% 2537
2021
Q4 		$1.92M Sell
12,042
-13,284
-52% -$2.11M ﹤0.01% 2580
2021
Q3 		$3.61M Buy
25,326
+11,158
+79% +$2.18M ﹤0.01% 2382
2021
Q2 		$1.31M Buy
14,168
+3,093
+28% +$1.31M ﹤0.01% 2897
2021
Q1 		$1.03M Sell
11,075
-92
-0.8% -$42.4K ﹤0.01% 2874
2020
Q4 		$1.04M Buy
11,167
+198
+2% +$116K ﹤0.01% 2792
2020
Q3 		$1.02M Sell
10,969
-1,933
-15% -$643K ﹤0.01% 2681
2020
Q2 		$1.23M Buy
12,902
+1,268
+11% +$111K ﹤0.01% 2539
2020
Q1 		$831K Sell
11,634
-818
-7% -$54.9K ﹤0.01% 2591
2019
Q4 		$859K Sell
12,452
-5,416
-30% -$402K ﹤0.01% 2739
2019
Q3 		$1.43M Buy
17,868
+13,716
+330% +$906K ﹤0.01% 2544
2019
Q2 		$267K Buy
+4,152
New +$394K ﹤0.01% 3132

Other funds holding MCRB

Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
J. Safra Sarasin Holding
J. Safra Sarasin Holding $7.05B AUM 26.14% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Rachor Investment Advisory Services
Rachor Investment Advisory Services Linden, Michigan $207M AUM 7.36% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

Nuveen's MCRB Position: Q3 2026 in Review

Nuveen opened a new position in Seres Therapeutics (MCRB) in Q3 2026: 1,773 shares worth $6.17K. The stake represents ﹤0.01% of the portfolio and ranks #4636 among its holdings. This is a return to the name: Nuveen previously reported a position in MCRB as recently as Q3 2023.

Nuveen first reported a position in MCRB in Q2 2019 and has held it in 19 quarters since. The position peaked at $3.61M in Q3 2021. 13 funds tracked by Wall St. Rank hold MCRB as of Q3 2026.

  • Nuveen held 1,773 shares of Seres Therapeutics worth $6.17K as of Q3 2026.
  • Seres Therapeutics was a new Nuveen position in Q3 2026.
  • Seres Therapeutics made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4636 holding.
  • Nuveen first reported a position in Seres Therapeutics in Q2 2019 and has held it in 19 quarters since.
  • Nuveen's Seres Therapeutics position peaked at $3.61M in Q3 2021.
  • 13 funds tracked by Wall St. Rank held Seres Therapeutics as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.